Showing results (211-220 of 305) with videos related to
Sort By:
Pageof 31
Journal of Cell Science|March 10, 2011
Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenanceBavo Heeman, Chris Van den Haute, Sarah-Ann Aelvoet, et al.The Journal of Clinical Endocrinology and Metabolism|October 18, 2017
Statins Affect Skeletal Muscle Performance: Evidence for Disturbances in Energy MetabolismNeeltje A E Allard, Tom J J Schirris, Rebecca J Verheggen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicityJ Tol, M Koopman, C J Rodenburg, et al.Neurology|February 19, 2024
Brody Disease, an Early-Onset Myopathy With Delayed Relaxation and Abnormal Gait: A Case Series of 9 ChildrenJamie I Verhoeven, Jasper Kramer, Juergen Seeger, et al.Molecular Genetics and Metabolism|March 14, 2016
Cytosolic phosphoenolpyruvate carboxykinase deficiency presenting with acute liver failure following gastroenteritisSaikat Santra, Jessie M Cameron, Casper Shyr, et al.Journal of Inherited Metabolic Disease|December 21, 2014
The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disordersWolfgang Sperl, Leanne Fleuren, Peter Freisinger, et al.American Journal of Human Genetics|July 6, 2010
Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defectHana Antonicka, Elsebet Ostergaard, Florin Sasarman, et al.International Journal of Molecular Sciences|July 13, 2024
Characterisation of an Adult Zebrafish Model for SDHB-Associated Phaeochromocytomas and ParagangliomasJasmijn B Miltenburg, Marnix Gorissen, Inge van Outersterp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III studyM Koopman, N F Antonini, J Douma, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerJ A Foekens, W L van Putten, H Portengen, et al.Pageof 31